A Device Master File (DMF) in Japan should be updated whenever there are significant changes to the device’s design, manufacturing processes, materials, or quality control procedures. Regular reviews are recommended to ensure compliance with the latest PMDA guidelines. Immediate updates are crucial... Read More
The requirements for a Device Master File (DMF) in Japan include detailed descriptions of the device’s design, manufacturing processes, materials, & quality control procedures. It must also include test data, stability data, and any proprietary methods. Compliance with PMDA guidelines is essential,... Read More
A Device Master File (DMF) in Japan is a confidential document submitted to the Pharmaceuticals & Medical Devices Agency (PMDA). It contains detailed information about the manufacturing process, quality controls, & components of a medical device. The DMF facilitates regulatory review &... Read More
Japan regulates Companion Diagnostic (CDx) products through the Pharmaceuticals and Medical Devices Agency (PMDA). These products undergo a stringent review, ensuring they effectively identify suitable treatments for patients. Evaluation integrates both drug and device assessments for safety and therapeutic alignment in personalized... Read More
Japan’s Companion Diagnostic (CDx) products are regulated by the Pharmaceuticals and Medical Devices Agency (PMDA). They undergo rigorous review, ensuring their ability to help determine specific drugs for patients. Evaluation integrates both drug and device assessment for safety and therapeutic alignment in... Read More
In Japan, IVD (In Vitro Diagnostic) registration is managed by the Pharmaceuticals and Medical Devices Agency (PMDA). The process involves a technical documentation review, clinical performance evaluation, and quality management system inspection. After successful evaluation, a marketing approval is granted by the... Read More
Taiwan’s drug registration process, overseen by the Taiwan Food and Drug Administration (TFDA), involves multiple stages: pre-clinical testing, clinical trials, application submission, review, and approval. The process ensures drug safety, efficacy, and quality. Special pathways also exist for priority or orphan drugs... Read More
Yes, Thailand has provisions for orphan drugs. The Thai FDA offers incentives like expedited approval processes and reduced fees to promote research and availability of treatments for rare diseases. These provisions aim to ensure that patients with uncommon conditions receive necessary medications... Read More
To register drugs in Indonesia, submit an application to the National Agency of Drug and Food Control (BPOM). Provide clinical trial data, efficacy and safety evidence, manufacturing information, and quality assurance documentation. BPOM reviews and, if compliant with regulations, grants approval for... Read More
The Korean GMP (Good Manufacturing Practice) guidelines ensure the consistent quality and safety of pharmaceutical products. They encompass standards for production, quality control, premises, equipment, and staff. Issued by the Korea MFDS, they set the benchmark for manufacturing, processing, packaging, and storing... Read More